Shorter regimens for tuberculosis preventive treatment: piecing together the global implementation jigsaw
- PMID: 36966789
- DOI: 10.1016/S2213-2600(23)00086-3
Shorter regimens for tuberculosis preventive treatment: piecing together the global implementation jigsaw
Conflict of interest statement
RvC reports grants from INTERCEPT and the National Institutes of Health (R01AI165721), and participation on a data safety monitoring board for two RCTs focused on tuberculosis meningitis, outside of the submitted work. Both authors are supported by the EU-funded consortium PROTID (Prevention of Tuberculosis in Diabetes; grant number RIA2018CO-2514).
Comment on
-
Completion, safety, and efficacy of tuberculosis preventive treatment regimens containing rifampicin or rifapentine: an individual patient data network meta-analysis.Lancet Respir Med. 2023 Sep;11(9):782-790. doi: 10.1016/S2213-2600(23)00096-6. Epub 2023 Mar 23. Lancet Respir Med. 2023. PMID: 36966788 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
